AssuredPartners Investment Advisors LLC purchased a new position in The Allstate Co. (NYSE:ALL – Free Report) in the fourth quarter, HoldingsChannel.com reports. The firm purchased 2,131 shares of the insurance provider’s stock, valued at approximately $411,000.
Several other large investors also recently bought and sold shares of ALL. JPMorgan Chase & Co. boosted its stake in shares of Allstate by 5.2% in the third quarter. JPMorgan Chase & Co. now owns 577,934 shares of the insurance provider’s stock valued at $109,605,000 after purchasing an additional 28,584 shares during the period. Ameritas Advisory Services LLC boosted its position in Allstate by 117.3% in the 4th quarter. Ameritas Advisory Services LLC now owns 4,896 shares of the insurance provider’s stock valued at $944,000 after buying an additional 2,643 shares during the last quarter. Hennessy Advisors Inc. boosted its position in Allstate by 6.9% in the 4th quarter. Hennessy Advisors Inc. now owns 58,600 shares of the insurance provider’s stock valued at $11,297,000 after buying an additional 3,800 shares during the last quarter. Los Angeles Capital Management LLC grew its stake in shares of Allstate by 10.5% during the fourth quarter. Los Angeles Capital Management LLC now owns 508,664 shares of the insurance provider’s stock valued at $98,065,000 after acquiring an additional 48,382 shares in the last quarter. Finally, Artemis Investment Management LLP increased its position in shares of Allstate by 33.3% during the fourth quarter. Artemis Investment Management LLP now owns 401,542 shares of the insurance provider’s stock worth $77,413,000 after acquiring an additional 100,311 shares during the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.
Insider Transactions at Allstate
In other Allstate news, CFO Jesse E. Merten sold 40,102 shares of the company’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the transaction, the chief financial officer now owns 18,115 shares in the company, valued at approximately $3,378,990.95. This represents a 68.88 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Insiders own 1.80% of the company’s stock.
Allstate Stock Performance
Allstate (NYSE:ALL – Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. As a group, sell-side analysts forecast that The Allstate Co. will post 18.74 earnings per share for the current year.
Allstate declared that its Board of Directors has initiated a share repurchase program on Wednesday, February 26th that allows the company to repurchase $1.50 billion in shares. This repurchase authorization allows the insurance provider to repurchase up to 3% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.
Allstate Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 1st. Stockholders of record on Monday, March 10th will be issued a dividend of $1.00 per share. This is an increase from Allstate’s previous quarterly dividend of $0.92. The ex-dividend date of this dividend is Monday, March 10th. This represents a $4.00 annualized dividend and a dividend yield of 1.91%. Allstate’s payout ratio is 23.54%.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on ALL shares. Barclays reduced their price target on Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a report on Monday, January 6th. Wells Fargo & Company increased their target price on Allstate from $186.00 to $187.00 and gave the company an “equal weight” rating in a research note on Tuesday, January 14th. Keefe, Bruyette & Woods lifted their price target on shares of Allstate from $235.00 to $240.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 11th. Evercore ISI upgraded shares of Allstate from an “in-line” rating to an “outperform” rating in a research note on Wednesday, January 8th. Finally, Argus raised shares of Allstate from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $217.94.
Check Out Our Latest Analysis on Allstate
About Allstate
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Further Reading
- Five stocks we like better than Allstate
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Top 3 Beverage Stocks Pouring Out Profits
- How to trade penny stocks: A step-by-step guide
- CarMax and Carvana: Steering the Used Car Market
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.